VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FONR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
FONRFONAR Corporation
$19.09$118M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksFONRFinancials

FONAR Corporation (FONR) Financials

30Y historyFree accessUpdated daily

Operating margins have experienced significant compression, falling from 19.2% in 2024Q2 to 9.2% in 2026Q3, as the company faces stagnant revenue growth and rising overhead costs.

FONR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97Jun'96
Sales/Revenue105.34M104.35M102.88M98.65M97.59M89.93M85.69M87.19M81.52M78.04M73.37M69.05M68.51M49.14M39.44M33.14M31.82M39.72M35.57M33.21M33.08M104.9M71.61M52.89M44.68M46.46M39.07M36.9M27.6M17.6M13.1M
Revenue Growth %2.25%1.43%4.3%1.08%8.52%4.95%-1.72%6.96%4.46%6.36%6.25%0.8%39.4%24.59%19.04%4.15%-19.91%11.68%7.1%0.41%-68.47%46.49%35.39%18.38%-3.83%18.9%5.89%33.7%56.82%34.35%-7.09%
Cost of Goods Sold62.93M61.44M57.74M52.9M50.58M46.46M43.3M43.98M41.95M38.05M38.87M38.4M37.25M26.12M21.2M18.48M18.62M22.12M24.89M26.66M26.95M66.72M44.41M32.48M26.24M31.98M26.98M25.9M21.3M11.8M6.7M
COGS % of Revenue-58.88%56.13%53.62%51.83%51.66%50.53%50.45%51.46%48.76%52.98%55.62%54.37%53.16%53.74%55.77%58.53%55.69%69.99%80.27%81.48%63.6%62.01%61.4%58.74%68.84%69.05%70.19%77.17%67.05%51.14%
Gross Profit42.41M42.91M45.14M45.75M47.01M43.47M42.39M43.21M39.57M39.98M34.5M30.65M31.26M23.02M18.25M14.66M13.2M17.6M10.68M6.55M6.13M38.18M27.2M20.41M18.43M14.48M12.09M11M6.3M5.8M6.4M
Gross Margin %40.26%41.12%43.87%46.38%48.17%48.34%49.47%49.55%48.54%51.24%47.02%44.38%45.63%46.84%46.26%44.23%41.47%44.31%30.01%19.73%18.52%36.4%37.99%38.6%41.26%31.16%30.95%29.81%22.83%32.95%48.85%
Gross Profit Growth %--4.94%-1.33%-2.69%8.14%2.55%-1.89%9.21%-1.05%15.91%12.56%-1.96%35.78%26.15%24.51%11.08%-25.02%64.86%62.95%6.93%-83.95%40.35%33.25%10.74%27.34%19.69%9.95%74.6%8.62%-9.38%-14.67%
Operating Expenses32.88M31.31M28.6M30.96M25.01M26.38M28.74M21.07M19.88M20.89M20.14M17.75M18.96M15.48M11.04M10.87M15.78M18.3M36.13M32M35.85M36.52M35.67M35.56M38.16M30.69M28.52M26.6M23.9M30.2M15.4M
OpEx % of Revenue-30%27.8%31.38%25.62%29.33%33.54%24.17%24.39%26.77%27.45%25.7%27.67%31.51%27.99%32.79%49.59%46.08%101.57%96.36%108.39%34.81%49.82%67.23%85.41%66.06%72.99%72.09%86.59%171.59%117.56%
Selling, General & Admin21.42M29.73M029.39M00019.26M18.13M19.41M18.71M13.46M15.39M12.5M8.75M8.46M11.94M13.42M22.6M26.31M27.35M29.88M29.55M28.91M31.84M23.61M18.32M15.3M14.5M24.3M9.5M
SG&A % of Revenue-28.49%-29.79%---22.09%22.24%24.87%25.5%19.49%22.46%25.44%22.18%25.54%37.53%33.79%63.53%79.22%82.68%28.48%41.26%54.65%71.26%50.81%46.88%41.46%52.54%138.07%72.52%
Research & Development1.77M1.58M1.74M1.57M1.49M1.64M2.03M1.81M1.76M1.48M1.63M1.81M1.76M1.44M1.24M1.44M2.46M3.59M5.01M5.69M6.87M6.01M5.49M5.16M5.1M5.87M5.53M6.6M6.5M3.9M3.6M
R&D % of Revenue-1.51%1.69%1.59%1.53%1.82%2.36%2.08%2.15%1.9%2.22%2.62%2.57%2.93%3.15%4.35%7.73%9.05%14.08%17.14%20.76%5.73%7.67%9.76%11.41%12.63%14.16%17.89%23.55%22.16%27.48%
Other Operating Expenses1000K026.87M023.51M24.74M26.72M1.06K-4.27K-1.16K0394.81K-608.6K-141.96K1.05M963.01K1.38M1.29M8.53M01.64M633.58K633.58K1.49M1.22M1.22M4.67M4.7M2.9M2M2.3M
Operating Income9.53M11.6M16.54M14.79M22.01M17.1M13.65M22.13M19.68M19.1M14.36M12.9M12.3M7.54M7.21M3.79M-2.58M-703.94K-25.45M-25.45M-29.72M1.66M-8.47M-15.15M-19.72M-16.21M-16.43M-15.6M-17.6M-24.4M-9M
Operating Margin %9.05%11.12%16.07%14.99%22.55%19.01%15.93%25.39%24.15%24.47%19.57%18.68%17.96%15.33%18.27%11.44%-8.11%-1.77%-71.56%-76.64%-89.87%1.59%-11.83%-28.64%-44.15%-34.9%-42.04%-42.28%-63.77%-138.64%-68.7%
Operating Income Growth %--29.85%11.81%-32.8%28.71%25.25%-38.33%12.45%3.08%33.02%11.28%4.85%63.26%4.57%90.07%246.91%-266.61%97.23%0%14.37%-1887.08%119.64%44.08%23.2%-21.64%1.29%-5.3%11.36%27.87%-171.11%-38.46%
EBITDA14.05M16.3M21.13M23.59M26.54M21.18M17.56M25.97M23.58M22.63M17.65M16.44M16.12M9.96M9.44M5.86M-1.14M1.03M-22.66M-22.78M-26.44M3.32M-6.93M-13.05M-16.66M-13.84M-11.76M-10.9M-14.7M-22.4M-6.7M
EBITDA Margin %13.34%15.62%20.54%23.92%27.2%23.55%20.49%29.79%28.93%29%24.06%23.81%23.53%20.26%23.92%17.7%-3.57%2.59%-63.7%-68.58%-79.93%3.16%-9.68%-24.68%-37.28%-29.79%-30.09%-29.54%-53.26%-127.27%-51.14%
EBITDA Growth %-15.49%-22.88%-10.44%-11.11%25.32%20.61%-32.39%10.12%4.22%28.19%7.35%2.01%61.9%5.51%60.91%616.39%-210.31%104.54%0.52%13.85%-897.5%147.84%46.92%21.63%-20.34%-17.74%-7.85%25.85%34.38%-234.33%-63.41%
D&A (Non-Cash Add-back)4.52M4.7M4.6M8.8M4.54M4.08M3.91M3.84M3.9M3.53M3.3M3.54M3.82M2.42M2.23M2.07M1.45M1.73M2.79M2.68M3.29M1.65M1.54M2.09M3.07M2.37M4.67M4.7M2.9M2M2.3M
EBIT9.53M11.6M16.54M15.81M22.01M17.1M13.65M22.62M19.68M19.1M14.36M12.9M12.3M8.48M7.49M3.9M-2.62M1.49M-12.98M-25.45M-29.72M2.36M-8.47M-15.15M-19.72M-16.21M-16.43M-15.6M-17.6M-24.4M-13.7M
Net Interest Income1.8M2.15M-77K-50.13K-346.55K-248.66K427.82K383.94K-160.07K28.3K-262.19K-702.1K-884.54K-500.36K-478.66K-290.36K-127.69K-312.41K-501.52K000000000000
Interest Income1.81M2.17M0000502.14K482.57K028.3K00000228.17K10.93K20.82K33.8K000000000000
Interest Expense12.61K25.61K77K50.13K346.55K248.66K74.32K98.64K160.07K0262.19K702.1K884.54K500.36K478.66K518.53K387.9K333.23K535.32K000000000000
Other Income/Expense1.84M2.18M2.73M969.33K761.69K567.72K498.6K385K98.22K220.28K152.63K-82.02K-1.25M442.72K-190.35K-406.98K-432.01K1.87M3.41M-86.3K854.3K466.55K-994.2K-757.49K-3.13M1.07M5.51M800K11.4M83.5M10.3M
Pretax Income11.38M13.78M19.27M15.76M22.77M17.67M14.15M22.52M19.78M19.32M14.51M12.82M11.05M7.98M7.02M3.38M-3.01M1.16M-13.52M-25.54M-29.91M1.08M-9.46M-15.9M-22.86M-15.14M-10.91M-14.8M-6.2M59.1M-3.4M
Pretax Margin %10.8%13.21%18.73%15.97%23.33%19.64%16.51%25.83%24.27%24.75%19.77%18.56%16.13%16.24%17.79%10.21%-9.47%2.91%-38%-76.9%-90.43%1.03%-13.22%-30.07%-51.15%-32.6%-27.93%-40.11%-22.46%335.8%-25.95%
Income Tax2.5M3.11M5.17M3.63M5.53M3.99M2.44M2.01M-5.67M-4.36M-4.29M-2.61M-2.35M-2.28M141.13K75.47K035.93K-6.94K86.3K54.03K64.04K29.89K-703.87K27.04K40K43.68K-600K-500K3M3.4M
Effective Tax Rate %21.94%22.55%26.83%23.05%24.31%22.6%17.28%8.91%-28.66%-22.58%-29.55%-20.38%-21.25%-28.55%2.01%2.23%0%3.11%0.05%-0.34%-0.18%5.94%-0.32%4.43%-0.12%-0.26%-0.4%4.05%8.06%5.08%-100%
Net Income6.69M8.33M10.57M9.38M12.44M10.21M8.24M15.32M21.23M19.62M15.72M12.91M10.4M8.68M5.78M3.16M-3.01M1.12M-13.51M-25.54M-29.96M1.01M-9.49M-15.01M-22.88M-15.18M-10.96M-14.2M-5.7M56.1M-3.4M
Net Margin %6.35%7.99%10.27%9.5%12.75%11.35%9.62%17.57%26.05%25.14%21.43%18.7%15.18%17.66%14.64%9.54%-9.47%2.82%-37.98%-76.9%-90.59%0.97%-13.26%-28.37%-51.22%-32.68%-28.04%-38.48%-20.65%318.75%-25.95%
Net Income Growth %-20.69%-21.13%12.71%-24.64%21.88%23.88%-46.2%-27.85%8.21%24.78%21.8%24.19%19.79%50.24%82.75%204.92%-368.69%108.3%47.11%14.77%-3053.77%110.68%36.73%34.42%-50.7%-38.59%22.85%-149.12%-110.16%1750%-88.89%
Net Income (Continuing)8.88M10.67M14.1M12.13M17.23M13.67M11.7M20.51M25.45M23.68M18.8M15.43M13.4M10.26M6.88M3.31M-3.01M1.12M-13.51M-25.54M-28.92M1.01M-9.49M-15.2M-22.88M-15.18M-10.96M-14.2M-5.7M56.1M-11.4M
Discontinued Operations0000000000000000000000000000000
Minority Interest-14.11M-12.5M-9.18M-7.08M-4.05M-3.05M55.25K2.16M3.56M5.47M8.4M12.39M20.59M23.69M6.1M7.31M063.81K166.97K531.94K696.86K522.56K381.02K345.12K272.31K152.97K21.52K0100K200K100K
EPS (Diluted)1.061.231.531.321.751.451.753.113.312.922.381.951.581.340.910.55-0.610.21-2.76-5.30-6.780.25-2.50-4.95-9.01-6.50-4.15-5.54-2.3225.00-1.64
EPS Growth %-19.35%-19.61%15.91%-24.57%20.69%-17.14%-43.73%-6.04%13.36%22.69%22.05%23.42%17.91%47.25%65.45%190.16%-390.48%107.61%47.92%21.83%-2812%110%49.49%45.06%-38.62%-56.63%25.09%-138.79%-109.28%1624.39%-64%
EPS (Basic)-1.261.561.351.781.471.793.183.382.982.432.001.621.370.930.56-0.610.21-2.76-5.30-6.780.25-2.50-4.95-9.01-6.50-4.97-5.54-2.3325.00-1.64
Diluted Shares Outstanding6.3M6.55M6.48M6.77M6.68M6.74M6.68M6.59M6.42M6.67M6.56M6.31M6.26M6.19M6.03M5.39M4.93M5.03M4.9M4.82M4.42M4.01M3.8M3.03M2.54M2.34M2.64M2.56M2.46M2.24M2.07M
Basic Shares Outstanding6.17M6.32M6.35M6.65M6.55M6.61M6.55M6.46M6.29M6.54M6.43M6.18M6.14M6.06M5.91M5.26M4.93M4.9M4.9M4.82M4.42M4.06M3.8M3.03M2.54M2.34M2.2M2.56M2.45M2.24M2.07M
Dividend Payout Ratio-----------------2.05%-------------

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetFortress
Cash FlowStable
Top Statement Risk

Regional regulatory reimbursement dependency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Stagnant Revenue Growth Amid Saturation

As reported in recent financial filings, FONR's revenue growth has remained largely stagnant, with the most recent quarter showing a 2.6% decline, suggesting that the company's niche diagnostic imaging model may be reaching a saturation point within its core New York and Florida geographic footprint.

The lack of consistent top-line expansion indicates that the company is struggling to scale its proprietary upright MRI technology beyond its existing facility base. Investors should monitor whether this trend reflects a broader decline in elective spinal imaging demand or an inability to capture new referral networks in a competitive healthcare landscape.

Structural Margin Volatility Remains Evident

Based on the provided income statement data, gross margins have fluctuated between 37.9% and 45.7% over the last ten quarters, reflecting the inherent difficulty in maintaining consistent profitability within a service-heavy model that relies on specialized labor and high-fixed-cost diagnostic imaging equipment maintenance.

The variability in gross margins suggests that the company lacks significant pricing power, likely due to its reliance on fixed reimbursement rates for specific CPT codes. This volatility warrants further investigation into whether rising operational costs or shifts in payer mix are exerting persistent pressure on the company's core service profitability.

Operating Leverage Constrained by Overhead

According to the company's historical income statements, operating margins have experienced significant compression, dropping from 19.2% in 2024Q2 to 9.2% in 2026Q3, which suggests that the company is failing to achieve meaningful operating leverage as SG&A expenses continue to consume a larger share of gross profit.

The inconsistent scaling of operating income relative to gross profit implies that administrative and management expenses are not being managed with sufficient discipline to offset revenue stagnation. This trend may indicate that the company's current cost structure is too rigid to adapt to the low-growth environment it currently faces.

Capital Underutilization Risks Shareholder Value

While the company maintains a fortress-like balance sheet with $56 million in cash, the lack of reinvestment into growth initiatives, as evidenced by the stagnant revenue figures, suggests that the firm may be prioritizing liquidity at the expense of long-term value creation for its shareholders.

Short-sellers might argue that the company's refusal to deploy its substantial cash reserves indicates a lack of confidence in the future viability of its upright MRI niche. Investors should consider whether this conservative capital allocation is a defensive necessity or a sign of strategic paralysis in a rapidly evolving medical imaging market.

FONR — Frequently Asked Questions

Quick answers to the most common questions about buying FONR stock.

What was FONAR Corporation's (FONR) revenue in 2025?

For fiscal year 2025, FONAR Corporation (FONR) reported total revenue of $104.4M. This represents a 696.6% increase compared to $13.1M in 1996.

Is FONAR Corporation (FONR) profitable?

FONAR Corporation (FONR) is profitable, generating $8.3M in net income for the fiscal year ending 2025 with a net profit margin of 8.0%.

What is FONAR Corporation's operating profit margin?

FONAR Corporation (FONR) reported an operating income of $11.6M, resulting in an operating profit margin of 11.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is FONAR Corporation's gross profit and gross margin?

FONAR Corporation (FONR) generated $42.9M in gross profit for the year, representing a gross profit margin of 41.1%. This demonstrates the company's core pricing power and production efficiency.